Concepedia

Entecavir Therapy

Entecavir Therapy is a nucleos(t)ide analog therapy that specifically employs the guanosine analog entecavir to selectively inhibit hepatitis B virus reverse transcriptase, thereby suppressing viral replication in chronic hepatitis B infection.

634

Publications

35.3K

Citations

3.7K

Authors

1.1K

Institutions

Publications per year

2017–2026

208

Parents

Publications

634

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

Ting‐Tsung Chang, Robert G. Gish, Robert de Man et al. · New England Journal of Medicine · 2006 · 1.4K citations · Full text

, , +10

Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

Ching‐Lung Lai, Daniel Shouval, Anna S. Lok et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

, , +11

Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡

Ting‐Tsung Chang, Yun‐Fan Liaw, Shun-Sheng Wu et al. · Hepatology · 2010 · 988 citations · Full text

, , +17

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2009 · 816 citations · Full text

, , +17

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi et al. · Hepatology · 2012 · 709 citations · Full text

, , +14

1–5 of 634

Authors

3.7K

  1. MY
    Man‐Fung Yuen

    University of Hong Kong, Hong Kong SAR China

    26 publications · 1.9K citations

    22

    h-index

  2. RJ
    Richard J. Colonno

    Bristol-Myers Squibb (United States), United States

    26 publications · 6.7K citations

    22

    h-index

  3. CL
    Ching‐Lung Lai

    University of Hong Kong, Hong Kong SAR China

    29 publications · 4.8K citations

    22

    h-index

  4. TH
    Tsung‐Hui Hu

    Kaohsiung Chang Gung Memorial Hospital, Taiwan

    29 publications · 1.1K citations

    20

    h-index

  5. HL
    Harry L.A. Janssen

    Erasmus MC, Netherlands

    22 publications · 1.9K citations

    18

    h-index

1–5 of 3.7K

Institutions

1.1K

  1. Bristol-Myers Squibb (United States)

    New York, United States

    41 h-index

    267 publications

    62.3K citations

  2. Chang Gung University

    Taoyuan City, Taiwan

    27 h-index

    231 publications

    10.4K citations

  3. University of Hong Kong

    Pok Fu Lam, Hong Kong

    24 h-index

    176 publications

    13K citations

  4. Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, Taiwan

    23 h-index

    226 publications

    8K citations

  5. Queen Mary Hospital

    Hong Kong, China

    21 h-index

    136 publications

    12.6K citations

  6. Bristol-Myers Squibb (Germany)

    Munich, Germany

    21 h-index

    84 publications

    17.3K citations

  7. Erasmus MC

    Rotterdam, The Netherlands

    21 h-index

    99 publications

    8.4K citations

  8. Yonsei University

    Seoul, South Korea

    21 h-index

    134 publications

    8.6K citations

1–8 of 1.1K

Venues

  1. Hepatology

    37 publications · 7.4K citations

    29

    h-index

  2. Journal of Hepatology

    42 publications · 3K citations

    28

    h-index

  3. Journal of Viral Hepatitis

    42 publications · 1.3K citations

    22

    h-index

  4. Hepatology International

    24 publications · 559 citations

    18

    h-index

  5. Antiviral Therapy

    29 publications · 855 citations

    17

    h-index

1–5